Published in Vaccine Weekly, October 10th, 2001
Several studies presented at an AIDS vaccine conference suggest that novel combinations of genes and other immune system stimulators may be able to keep HIV at bay, even if they fail to prevent infection.
Testing in people has just begun, and no one knows if they will truly work. Even if they do, it may take a decade of fine-tuning and large-scale testing before they reach widespread use.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly